Xiromed, LLCUsage: Fulvestrant injection is indicated for treating HR-positive, HER2-negative advanced breast cancer in postmenopausal women. It can be used alone in those not previously treated with endocrine therapy or with disease progression after treatment. It is also indicated in combination with ribociclib, palbociclib, or abemaciclib.